Abstract: The present disclosure relates to the biopharmaceutical field, in particular, Exatecan derivatives, linker-payloads, and conjugates and thereof antibody-drug conjugates, and the corresponding preparing process and use thereof.

Abstract: An unmanned aerial vehicle (UAV)-assisted hanging ring robot for live installation and grounding includes a hanging tray, a wire hanging bracket, a hanging wire, an overturning stay wire, an overturning frame, a support, an electric lock, a walking wheel, a driving motor, a workbench, a clamp seat, a puncture clamp, a tightening mechanism, a remote controller, and a controller. The hanging tray is installed at the bottom of a UAV, one end of the overturning stay wire is connected to the overturning frame, the other end thereof hangs on ground, the driving motor is installed on the overturning frame, the walking wheel is connected to the driving motor, the puncture clamp is installed on the clamp seat, the tightening mechanism is installed on the workbench, and connected to the puncture clamp, and the electric lock, tightening mechanism, driving motor, and remote controller are connected to the controller.

Abstract: Disclosed are a molecular imaging method using Raman spectra and system based on machine learning cascade. The system includes a coordinate localization module, a hierarchical clustering analysis module, a Raman predictive imaging module, and a similarity analysis module. An untreated frozen tissue slice is attached to a stainless steel slide, and an adjacent slice is attached to a glass slide. The coordinate localization module can match a Raman white light image of a detection sample attached to the stainless steel slide with an immunohistochemistry (IHC) image of the adjacent slice, such that Raman spectra of a target region are accurately collected. The hierarchical clustering analysis module purifies different types of Raman spectra. A machine learning classifier is configured to build a Raman predictive imaging model. The similarity analysis module can evaluate similarity between a predicted Raman predictive image and the IHC image of the adjacent slice.

Abstract: A profile or article formed from a moisture- and/or thermo-curable elastomeric polymer composition including: (A) at least one ethylene-olefinic monomer-silane polymer; wherein the polymer has an olefinic monomer content of from 5 weight percent to 50 weight percent and a silane content of from 0.1 weight percent to 2.5 weight percent; and wherein the polymer has a melt index of from 0.1 gram/10 minutes to 10.0 grams/10; and (B) at least one silanol condensation catalyst; a shaped article made from the above elastomeric polymer composition; and a method of making a shaped article using the above elastomeric polymer composition.

Abstract: The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted benzothiazole compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Abstract: The disclosure relates to method and apparatus for fusing layers of different models. The method for fusing layers of different models comprises: searching layers from different models and determining whether to perform layer fusing; fusing instructions in the layers from different models into a fused instruction in response to determining to perform layer fusing; combining input data for the instructions in the layers from different models into a combined input data; allocating a continuous storage area in a memory for the combined input data; loading the combined input data for the fused instruction from the continuous storage area in the memory to perform the fused instruction; and storing output data obtained after performing the fused instruction into a continuous storage area in the memory.

Abstract: The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Abstract: The present disclosure relates to the biopharmaceutical field, in particular, Exatecan derivatives, linker-payloads, and conjugates and thereof antibody-drug conjugates, and the corresponding preparing process and use thereof.

Abstract: Disclosed are quinoline and quinazoline compounds which modulate the activity of the gated ion channels. Compounds that modulate these gated ion channels are useful in the treatment of diseases and disorders related to pain, inflammation, the neurological system, the gastrointestinal system and genitourinary system. Preferred compounds include quinoline or quinazoline derivatives substituted at the 4-position via N(H), C(O) or O moieties.

Abstract: A group of tropomyosin receptor kinase inhibitors including an amido-phenoxy-indazole structure fragment. These compounds show potent inhibitory effects on various oncogenic kinases, especially TRK, and thus can be used to treat tumors or cancers.

Abstract: The present disclosure relates to the biopharmaceutical field, in particular, Exatecan derivatives, linker-payloads, and conjugates and thereof antibody-drug conjugates, and the corresponding preparing process and use thereof.

Abstract: The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted bicyclic heterocyclic and heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Abstract: The present disclosure relates to the biopharmaceutical field, in particular, Exatecan derivatives, linker-payloads, and conjugates and thereof antibody-drug conjugates, and the corresponding preparing process and use thereof.

Abstract: The present disclosure relates to the biopharmaceutical field, in particular, Exatecan derivatives, linker-payloads, and conjugates and thereof antibody-drug conjugates, and the corresponding preparing process and use thereof.

Abstract: The present description relates to compounds of Formula (I), forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Abstract: The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted bicyclic heteroaryl compounds of Formula (I), Formula (II), Formula (III), or Formula (IV), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Abstract: A group of tropomyosin receptor kinase inhibitors including an amido-phenoxy-indazole structure fragment. These compounds show potent inhibitory effects on various oncogenic kinases, especially TRK, and thus can be used to treat tumors or cancers.

Abstract: A sewage treatment apparatus comprises an external box body internally being provided with an anaerobic zone, an aerobic zone, a settling zone, a sewage reduction zone and an apparatus zone separated from each other, wherein the anaerobic zone, the aerobic zone, the settling zone and the sewage reduction zone communicate in sequence, the anaerobic zone communicates with a septic tank, the aerobic zone communicates with the anaerobic zone to reflux a part of mixed liquid to the anaerobic zone, the settling zone communicates with the anaerobic zone to reflux a part of active sludge to the anaerobic zone, and the sludge reduction zone communicates with the anaerobic zone or the septic tank; and the apparatus zone is internally provided with a detection unit for detecting various parameters during a sewage treatment process and a controller for controlling working states according to a detection result of the detection unit.

Abstract: The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted bicyclic heteroaryl compounds of Formula (I), Formula (II), Formula (III), or Formula (IV), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Abstract: The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted benzothiazole compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.